C.R. Bard, Inc. (NYSE:BCR)

CAPS Rating: 4 out of 5

The Company is engaged in the design, manufacture, packaging, distribution and sale of medical, surgical, diagnostic and patient care devices.


Player Avatar woppi (82.60) Submitted: 10/5/2009 3:57:03 PM : Outperform Start Price: $74.04 BCR Score: +30.40

Low debt, high profit margins for the industry (just under 20%) and a nice steady increase in Total Cash from Operations down through the years. Operating expenses have also risen over the same period, but not as much indicating that management have a good handle on things. I think the impact of the Obama plan is already built into the current price, so I don't expect a lift from that.

Featured Broker Partners